Hospital
Mount Desert Island Hospital
Mount Desert Island Hospital was paid $1.57M by Medicaid between Jan 2018 and Dec 2024, across 148 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoMOUNT DESERT ISLAND HOSPITAL
BAR HARBOR, ME 04609
BAR HARBOR, ME 04609
33aNPI1790764512assigned 01/11/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$1.57M
24GClaims214,986
24DCodes billed148
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,823 | $180K | |
| 2019 | 27,820 | $192K | |
| 2020 | 26,613 | $185K | |
| 2021 | 33,585 | $256K | |
| 2022 | 34,536 | $244K | |
| 2023 | 37,392 | $255K | |
| 2024incomplete | 31,217 | $256K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 32,010 | 21,897 | $497K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 32,065 | 23,229 | $345K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.1% | 2,626 | 1,847 | $127K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 5.6% | 9,712 | 3,620 | $88K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.2% | 4,674 | 3,014 | $81K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.7% | 4,648 | 2,965 | $59K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 274 | 215 | $31K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.8% | 5,867 | 1,634 | $29K |
| 80053 | Comprehensive metabolic panel | 1.5% | 10,152 | 8,705 | $23K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 2,335 | 1,930 | $23K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 1,336 | 1,078 | $21K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 785 | 546 | $18K |
136 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 796 | $16K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 239 | $16K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 137 | $13K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,069 | $13K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,082 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,079 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 697 | $10K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 890 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,638 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,368 | $9K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 745 | $7K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,929 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,985 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,755 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 594 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 17,768 | $5K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 19 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 771 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,917 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 290 | $3K |
| 80061 | Lipid panel | <1% | 3,643 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 564 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 646 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 43 | $3K |
| 90837 | Psychotherapy session, about an hour | <1% | 246 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 790 | $2K |
| 82607 | <1% | 612 | $2K | |
| 84484 | <1% | 1,192 | $2K | |
| 83735 | <1% | 3,144 | $2K | |
| 85027 | <1% | 1,829 | $2K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,499 | $2K |
| 90686 | <1% | 1,383 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,218 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,412 | $2K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 97 | $1K |
| 82043 | <1% | 628 | $1K | |
| 97161 | <1% | 224 | $1K | |
| 83880 | <1% | 451 | $1K | |
| 82728 | <1% | 485 | $1K | |
| 86140 | <1% | 2,050 | $1K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 327 | $968.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,029 | $951.12 |
| 81003 | <1% | 2,328 | $804.00 | |
| 99205 | Prolong outpt/office vis | <1% | 56 | $768.91 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,182 | $753.88 |
| 85610 | <1% | 2,447 | $644.47 | |
| 84466 | <1% | 430 | $635.88 | |
| J2704 | Injection, propofol, 10 mg | <1% | 507 | $634.42 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 730 | $622.01 |
| 84439 | <1% | 333 | $611.22 | |
| 83540 | <1% | 693 | $593.11 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 540 | $519.08 |
| 82570 | <1% | 420 | $518.67 | |
| 87077 | <1% | 207 | $514.67 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 944 | $490.30 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 416 | $461.95 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 257 | $458.19 |
| 85652 | <1% | 907 | $431.95 | |
| 90715 | <1% | 186 | $421.48 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 32 | $410.72 |
| 86618 | <1% | 253 | $409.76 | |
| 82803 | <1% | 214 | $381.94 | |
| 81001 | <1% | 750 | $363.38 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 469 | $346.59 |
| 87631 | <1% | 457 | $317.21 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 45 | $304.67 |
| 83605 | <1% | 338 | $290.99 | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 66 | $231.11 |
| 81002 | <1% | 2,146 | $229.20 | |
| 83690 | <1% | 693 | $195.16 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 605 | $194.32 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 39 | $186.64 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 54 | $184.66 |
| 83550 | <1% | 245 | $163.72 | |
| 84703 | <1% | 539 | $152.13 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 18 | $143.66 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 578 | $133.40 |
| 84153 | <1% | 27 | $132.96 | |
| 81015 | <1% | 303 | $114.10 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 553 | $102.44 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 18 | $100.66 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 14 | $68.00 |
| 85730 | <1% | 14 | $65.54 | |
| 86803 | <1% | 82 | $48.27 | |
| 0001A | <1% | 45 | $40.00 | |
| 95909 | <1% | 16 | $37.46 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $36.00 |
| 97803 | <1% | 13 | $34.24 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 383 | $32.59 |
| 87205 | <1% | 98 | $28.73 | |
| J3490 | Unclassified drugs | <1% | 13 | $26.03 |
| 87469 | <1% | 43 | $24.42 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 91 | $24.30 |
| 83721 | <1% | 13 | $23.59 | |
| G0008 | Administration of influenza virus vaccine | <1% | 778 | $20.07 |
| 87484 | <1% | 43 | $19.07 | |
| 87468 | <1% | 43 | $19.07 | |
| 87478 | <1% | 43 | $19.07 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,043 | $14.40 |
| 90670 | <1% | 40 | $12.26 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 46 | $10.12 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 185 | $7.56 |
| 86900 | <1% | 16 | $5.18 | |
| 84481 | <1% | 12 | $2.38 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 544 | $0.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 946 | $0.00 |
| 90633 | 0% | 101 | $0.00 | |
| 90662 | 0% | 150 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 1,065 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 335 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 214 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 164 | $0.00 |
| 91300 | 0% | 204 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 348 | $0.00 |
| 80305 | 0% | 31 | $0.00 | |
| 81025 | 0% | 39 | $0.00 | |
| 0004A | 0% | 72 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 26 | $0.00 |
| 91322 | 0% | 77 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 14 | $0.00 |
| 0071A | 0% | 13 | $0.00 | |
| 0002A | 0% | 53 | $0.00 | |
| 90734 | 0% | 15 | $0.00 | |
| 90656 | 0% | 289 | $0.00 | |
| 90480 | 0% | 102 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 73 | $0.00 |
| 87070 | 0% | 12 | $0.00 | |
| 90677 | 0% | 65 | $0.00 | |
| 87081 | 0% | 26 | $0.00 | |
| 87040 | 0% | 43 | $0.00 | |
| 86592 | 0% | 14 | $0.00 | |
| 86702 | 0% | 14 | $0.00 | |
| 87390 | 0% | 14 | $0.00 | |
| 76830 | Ultrasound, transvaginal | 0% | 17 | $0.00 |
| 86701 | 0% | 14 | $0.00 | |
| 0072A | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABBOTT, JENNIFER (QUALITY & COMPLIANCE SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Mount Desert Island Hospital | Southwest Harbor, ME | $53K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.